{'fraction_non_alphanumeric': 0.014035087719298246, 'fraction_numerical': 0.0, 'mean_word_length': 5.415730337078652, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy

Among the several proposed risk classification schemes for predicting survival in women with breast carcinoma, one of the most commonly used is the Nottingham Prognostic Index (NPI). The goal of the current study was to use a continuous prognostic model (similar to those that have already been demonstrated to possess greater predictive accuracy than risk group–based models in other malignancies) to predict breast carcinoma mortality more accurately compared with the NPI.